Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Diathermy for 23-gauge sclerotomy: a functional and morphologic study to avoid ocular hypotony.

Authors:
Soraya Horowitz Nadyr A Damasceno Felipe Muralha Maurício B Pereira Mauricio Maia Eduardo F Damasceno

Clin Ophthalmol 2019 4;13:1703-1710. Epub 2019 Sep 4.

Department of Ophthalmology, Universidade Federal Fluminense, Niterói, Brazil.

Purpose: To evaluate diathermy to minimize sclerotomy leakage during small-gauge vitrectomy and prevent ocular hypotony.

Methods: This observational prospective study included 327 patients (327 eyes) who underwent diathermy to close the sclerotomy sites during 23-gauge pars plana vitrectomy (PPV). All patients were operated by a single surgeon (ED) and evaluated at 30 and 60 days postoperatively. Patients with glaucoma, topical/systemic steroids use exceeding 30 days, ocular inflammation, or trauma were excluded. Chi-square, Kruskal-Wallis, Fisher Exact test, and multivariate statistical analyses were performed to evaluate potential risk factors. The primary outcomes were open sclerotomies, leakage, and ocular hypotony.

Results: Sclerotomies remained open in 12 (3.6%) and 2 (0.6%) patients, respectively, at 30 and 60 days postoperatively, revealing no case of ocular hypotony. Leakage only occurred in four patients (1.2%) during week 1 postoperatively. Multivariate analysis indicated that additional vitreoretinal surgeries and longer surgeries were risk factors for persistent sclerotomy opening.

Conclusion: Diathermy was safe and feasible to close sclerotomies. Vitreoretinal surgery reoperations and longer surgeries were the most significant (<0.05) risk factors for persistent sclerotomy opening, which may be functionally closed without evidence of leakage or ocular hypotony.

Download full-text PDF

Source
http://dx.doi.org/10.2147/OPTH.S209813DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732740PMC
September 2019

Publication Analysis

Top Keywords

ocular hypotony
8
longer surgeries
8
days postoperatively
8
risk factors
8
ocular
5
patients
5
inflammation trauma
4
indicated additional
4
ocular inflammation
4
diathermy
4
analysis indicated
4
kruskal-wallis fisher
4
fisher exact
4
postoperatively multivariate
4
multivariate analysis
4
chi-square kruskal-wallis
4
days ocular
4
excluded chi-square
4
trauma excluded
4
topical/systemic steroids
4

Similar Publications

Multiple Penetrating Eye Wounds Due to Suspected Self-Injury.

Authors:
José Dalma-Weiszhausz José Arturo Oyervides Alvarado Ana Maria Suarez Licona Miriam Tatiana Serment Azuara Alejandro Dalma Kende

Turk J Ophthalmol 2021 Feb;51(1):58-61

Dalma & Asociados, SC. Cuidad de México, México.

We present a case of a 29-year-old male night watchman complaining of sudden decreased vision, redness, and tearing of the left eye. On anamnesis, trauma was denied and personal past history was relevant for right eye enucleation due to an "eye injury" 8 years prior. At presentation, his visual acuity was 20/200 and intraocular pressure (IOP) was 10 mmHg. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Bilateral anterior segment dysgenesis and peripheral avascular retina with tractional retinal detachment in an infant with multiple congenital anomalies-hypotony-seizures syndrome 3.

Authors:
Frances Wu Paula C Goldenberg Shizuo Mukai

Ophthalmic Genet 2021 Feb 23:1-4. Epub 2021 Feb 23.

Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts, USA.

: Multiple congenital anomalies-hypotony-seizures syndrome 3 (MCAHS3) is a rare autosomal recessive disorder caused by mutations in the gene. encodes phosphatidylinositol-glycan biosynthesis class T, which plays a crucial role in protein anchoring to cell membranes. The clinical presentation of MCAHS3 is variable in expression and severity, but can be characterized by developmental delay, seizures, hypotonia, facial dysmorphism, and other abnormalities. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Irreversible chorioretinal changes related to post-surgical hypotony maculopathy: Report of three cases.

Authors:
E Ávila-Marrón C Arciniegas-Perasso C Macià Badia J P Liscombe-Sepúlveda S Duch-Tuesta

J Fr Ophtalmol 2021 Feb 16. Epub 2021 Feb 16.

Unidad de glaucoma, Innova ocular ICO Barcelona, Calle Vía Augusta, 61, 08006 Barcelona, Spain.

View Article and Full-Text PDF
February 2021
Similar Publications

Association between vascular comorbidity and glaucoma progression: A four-year observational study.

Authors:
Ana Maria Dascalu Daniela Stana Vanesa Andrada Nicolae Catalin Cirstoveanu Geta Vancea Dragos Serban Bogdan Socea

Exp Ther Med 2021 Mar 26;21(3):283. Epub 2021 Jan 26.

Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Glaucoma, one of the significant causes of blindness worldwide, is a chronic optic neuropathy, characterized by progressive loss of retinal ganglion cells and specific perimetric defects. This study aimed to assess the association between the risk of glaucoma progression and different systemic vascular abnormalities. A 4-year prospective study was carried out on 204 patients diagnosed with open-angle glaucoma. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Experience in managing glaucoma filtration surgery complications with oral doxycycline: A case series.

Authors:
Geng-Yi Yong Jelinar Mohamed-Noor Poh-Yan Ong Nurull Bahya Suliman Ching-Wei Lim Mimiwati Zahari

Eur J Ophthalmol 2021 Feb 7:1120672121992953. Epub 2021 Feb 7.

Department of Ophthalmology, University of Malaya, Kuala Lumpur, Malaysia.

Purpose: To report the clinical profile and effectiveness of oral doxycycline as a non-invasive treatment for glaucoma filtering surgery complications.

Method: Prospective case series.

Results: Doxycycline is widely used in treating corneal melts, ocular surface diseases, meibomian gland disease, recurrent epithelial cell erosion, rosacea, and keratitis sicca. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap